#tudriqev
Related Stories (1)
Related Pages (2)
Replimune’s drug for advanced skin cancer fails to win FDA nod again
By Padmanabhan Ananthan and Sruthi Narasimha Chari April 10 (Reuters) – The U.S. Food and Drug Administration on Friday declined to approve Replimune’s drug for advanced skin cancer, citing insuffici
1027wbow.com•April 12, 2026
Replimune’s drug for advanced skin cancer fails to win FDA nod again
By Padmanabhan Ananthan and Sruthi Narasimha Chari April 10 (Reuters) – The U.S. Food and Drug Administration on Friday declined to approve Replimune’s drug for advanced skin cancer, citing insuffici
y94.com•April 12, 2026